Riverview Trust CO Royalty Pharma PLC Transaction History
Riverview Trust CO
- $108 Million
- Q4 2024
A detailed history of Riverview Trust CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Riverview Trust CO holds 1,216 shares of RPRX stock, worth $40,638. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,216
Previous 30
3953.33%
Holding current value
$40,638
Previous $0
Infinity%
% of portfolio
0.03%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
429Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$769 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$567 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$472 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...